PMID: Int J Mol Sci. 2020 Mar 7 ;21(5). Epub 2020 Mar 7. PMID: 32155978 Abstract Title: Curcumin as an Anticancer Agent in Malignant Mesothelioma: A Review. Abstract: Malignant mesothelioma is an infrequent tumor that initiates from the mesothelial cells lining of body cavities. The great majority of mesotheliomas originate in the pleural cavity, while …
Continue reading “Curcumin as an anticancer agent in malignant mesothelioma.”
PMID: Chem Biol Interact. 2020 Apr 1 ;320:109022. Epub 2020 Feb 27. PMID: 32112862 Abstract Title: Thymoquinone suppresses invasion and metastasis in bladder cancer cells by reversing EMT through the Wnt/β-catenin signaling pathway. Abstract: Epithelial mesenchymal transformation plays a crucial role in the metastasis of bladder cancer, which makes bladder cancer difficult to cure. Bladder …
Continue reading “Thymoquinone suppresses invasion and metastasis in bladder cancer cells.”
PMID: Iran J Basic Med Sci. 2019 Dec ;22(12):1432-1439. PMID: 32133061 Abstract Title: Effects of thymoquinone in prevention of experimental contrast-induced nephropathy in rats. Abstract: Objectives: This study aimed to show the effects of thymoquinone, which is known for its antioxidant, anti-inflammatory, and renal protective effects in contrast-induced nephropathy.Materials and Methods: This is an experimental …
PMID: Food Chem Toxicol. 2020 Mar 9:111253. Epub 2020 Mar 9. PMID: 32165235 Abstract Title: Thymoquinone induces apoptosis of human renal carcinoma Caki-1 cells by inhibiting JAK2/STAT3 through pro-oxidant effect. Abstract: Currently, there are limited effective treatment options for renal cell carcinoma (RCC), due to its poor responses to conventional therapies. Instead of using extrinsic anti-cancer …
Continue reading “Thymoquinone induces apoptosis of human renal carcinoma Caki-1 cells.”
PMID: Ann Ital Chir. 2020 ;91:131-136. PMID: 32180584 Abstract Title: Comparison of the effects of thymoquinone and silymarin on the brain of rats having ischemia-reperfusion in the lower extremities. Abstract: AIM: We aimed to show whether ischemia reperfusion (I/R) injury causes damage on brain or not, and whether thymoquinone and silymarin, as antioxidant and anti-inflammatory …
PMID: Cureus. 2020 Feb 13 ;12(2):e6979. Epub 2020 Feb 13. PMID: 32089976 Abstract Title: The Carotenoid Compound of Saffron Crocetin Alleviates Effects of Ischemia Reperfusion Injury via a Mechanism Possibly Involving MiR-127. Abstract: Renal impairment is associated with high mortality rates in severely ill patients. The need to prevent and treat renal damage underlines the …
PMID: Sci Rep. 2020 Feb 27 ;10(1):3654. Epub 2020 Feb 27. PMID: 32107408 Abstract Title: Delivering Crocetin across the Blood-Brain Barrier by Usingγ-Cyclodextrin to Treat Alzheimer's Disease. Abstract: Crocetin (CRT) has shown various neuroprotective effects such as antioxidant activities and the inhibition of amyloidβ fibril formation, and thus is a potential therapeutic candidate for Alzheimer's …
PMID: Front Med. 2020 Mar 13. Epub 2020 Mar 13. PMID: 32170559 Abstract Title: Combination of western medicine and Chinese traditional patent medicine in treating a family case of COVID-19 in Wuhan. Abstract: In December 2019, an outbreak of novel Coronavirus (2019-nCoV) occurred in Wuhan, Hubei Province, China. By February 14, 2020, it has led …
PMID: Chin J Integr Med. 2020 Feb 17. Epub 2020 Feb 17. PMID: 32065348 Abstract Title: Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019 (COVID-19)? A Review of Historical Classics, Research Evidence and Current Prevention Programs. Abstract: OBJECTIVE: Since December 2019, an outbreak of corona virus disease 2019 (COVID-19) occurred in …
PMID: J Integr Med. 2020 03 ;18(2):87-88. Epub 2020 Feb 19. PMID: 32122812 Abstract Title: Traditional Chinese medicine is a resource for drug discovery against 2019 novel coronavirus (SARS-CoV-2). Abstract: [n/a] read more
Health Time